Cargando...
Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?
Understanding the molecular defects underlying cardiovascular disease is necessary for the development of therapeutics. The most common method to lower circulating lipids, which reduces the incidence of cardiovascular disease, is statins, but other drugs are now entering the clinic, some of which ha...
Guardado en:
| Publicado en: | Biochim Biophys Acta |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5953829/ https://ncbi.nlm.nih.gov/pubmed/29627384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbalip.2018.03.010 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|